• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

CMS Grants AABB as an Accrediting Organization for Laboratories Performing HLA Testing

May 23, 2014

Facilities performing human leukocyte antigen (HLA) testing for clinical use must be accredited.  The Centers of Medicare and Medicaid Services (CMS) announced that HLA testing of blood donors for transfusion related acute lung injury (TRALI) risk reduction can be classified as either histocompatibility or general immunology.  This classification allows the AABB to be an accrediting organization.  If there are any questions concerning laboratory accreditation of HLA testing, they should be directed to the AABB accreditation department.

Reference

1. AABB Weekly Report. May 9, 2014.  Vol 20.  No 16.

Filed Under

  • News
  • Policy and Guidelines
  • Quality Control and Regulatory

Recommended

  • Surveys Report Fewer Blood Collections and Transfusions in 2013

  • No Evidence of Transfusion-Transmission of Neurodegenerative Disorders

  • Intrinsic Platelet Reactivity does not Affect Transfusion Outcome

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley